Suppr超能文献

Δ40p53 对 p53 功能和黑色素瘤细胞命运的主导作用。

Dominant effects of Δ40p53 on p53 function and melanoma cell fate.

机构信息

Medical Scientist Training Program, Mayo Clinic, Rochester, Minnesota, USA; Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Minnesota, USA; Kogod Center on Aging, Mayo Clinic, Rochester, Minnesota, USA.

Internal Medicine/Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA; Oncology/Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA; Immunology, Mayo Clinic, Rochester, Minnesota, USA.

出版信息

J Invest Dermatol. 2014 Mar;134(3):791-800. doi: 10.1038/jid.2013.391. Epub 2013 Sep 13.

Abstract

The TP53 gene encodes 12 distinct isoforms, some of which can alter p53 activity in the absence of genomic alteration. Endogenous p53 isoforms have been identified in cancers; however, the function of these isoforms remains unclear. In melanoma, the frequency of TP53 mutations is relatively low compared with other cancers, suggesting that these isoforms may have a larger role in regulating TP53 activity. We hypothesized that p53 function and therefore cell fate might be altered by the presence of Δ40p53, an embryonic isoform missing the first 40 N-terminal amino acids of the full-length protein including the transactivation and Mdm2-binding domains. To test this hypothesis, we transduced tumor and normal cells with a lentivirus encoding Δ40p53. We found that exogenous Δ40p53 caused apoptosis and increased the levels of endogenous, activated p53 in both cancerous and non-cancerous cells, which led to significant levels of cell death, particularly in cancer cells. Activated p53 molecules formed nuclear heterotetramers with Δ40p53 and altered downstream p53 transcription target levels including p53-induced protein with death domain and cyclin-dependent kinase inhibitor, p21. Δ40p53 altered the promoter occupancy of these downstream p53 target genes in such a way that it shifted cell fate toward apoptosis and away from cell cycle arrest. We show that tumor suppression by p53 can occur via an alternate route that relies on its interaction with Δ40p53.

摘要

TP53 基因编码 12 种不同的异构体,其中一些在没有基因组改变的情况下可以改变 p53 的活性。已经在癌症中鉴定出内源性 p53 异构体;然而,这些异构体的功能仍不清楚。与其他癌症相比,黑色素瘤中 TP53 突变的频率相对较低,这表明这些异构体可能在调节 TP53 活性方面发挥更大的作用。我们假设,p53 功能,因此细胞命运可能会被缺失全长蛋白第一个 40 个 N 端氨基酸的胚胎异构体 Δ40p53 改变,包括转录激活和 Mdm2 结合结构域。为了验证这一假设,我们用携带 Δ40p53 的慢病毒转导肿瘤和正常细胞。我们发现外源性 Δ40p53 导致凋亡,并增加了致癌和非致癌细胞中内源性、激活的 p53 水平,导致显著水平的细胞死亡,特别是在癌细胞中。激活的 p53 分子与 Δ40p53 形成核异源四聚体,并改变下游 p53 转录靶标水平,包括死亡结构域诱导蛋白和细胞周期蛋白依赖性激酶抑制剂 p21。Δ40p53 以一种改变这些下游 p53 靶基因启动子占据的方式改变了细胞命运,使其向凋亡而不是细胞周期阻滞转变。我们表明,p53 的肿瘤抑制作用可以通过依赖于其与 Δ40p53 相互作用的另一种途径发生。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c99a/3945389/775e1441d865/nihms521508f1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验